Amneal Lines Up Launches As It Builds Out Biosimilars Business

Generics Sales Remain Flat In Q3, But Alymsys Bevacizumab Biosimilar Makes Solid Start

 
• By Dave Wallace
  
Dominoes lined up
Amneal is lining up multiple imminent biosimilar and generic launches • Source: Shutterstock

More from Strategy

More from Business